Therapeutic areas

We prioritise innovation to make the world’s diseases a thing of the past.

DSC 2419

To get ahead of disease

Globally, we prioritise research into vaccines and medicines across our four therapeutic areas. We also remain open to opportunities outside these core areas where the science aligns with our strategic approach.

Infectious diseases

For over 70 years, we have been pioneering research methods to help protect people from infections.

HIV science image

HIV

Our work in HIV is carried out entirely through ViiV Healthcare, which GSK majority owns with Pfizer

Oncology

Our expertise in oncology allows us to bring groundbreaking cancer therapies to our patients.

Lupus science image

Respiratory/ Immunology

We’re focused on unlocking the science of the immune system to understand how the bodies react.

Explore our innovation stories

Innovation is at the very core of GSK. Discover how we're uniting science, technology and talent to get ahead of disease together.

BEHIND THE SCIENCE

How adjuvants boost our immune response

Innovation stories of GSK

BEHIND THE SCIENCE

Fresh insights could finally help us tackle respiratory syncytial virus (RSV)

GSK - Innovation stories

BEHIND THE SCIENCE

What if remission were the Target of Lupus Care?

Explore the innovation stories of GSK

BEHIND THE SCIENCE

Tackling tomorrow’s health challenges today

Innovation stories

BEHIND THE SCIENCE

Could tiny bubbles released from bacteria cells pave the way for new vaccine technology

Explore the innovation stories

Global Behind the science magazine

You might also like

Continue to Clinical trials at GSK